news reports say Iambic Therapeutics, Inc. is expected to list on October 15, 2026
News reports indicate that Iambic Therapeutics, Inc. is expected to list on October 15, 2026. This biotech firm focuses on enhancing drug…
Biotech

#IPO #Biotech #BiologicalProductsNoDiagnostic #UnitedStates #IPONews

Iambic Therapeutics, Inc. filed for an IPO
Iambic Therapeutics has filed for an IPO, advancing its mission to transform drug discovery with a proprietary AI-driven platform.
Biotech

#IPO #Biotech #BiologicalProductsNoDiagnostic #UnitedStates #IPONews

news reports say TRex Bio, Inc. is expected to list on October 9, 2026
News reports indicate TRex Bio, Inc. is expected to list on October 9, 2026. The biotech company focuses on partnerships and…
Biotech

#IPO #Biotech #BiologicalProductsNoDiagnostic #UnitedStates #IPONews #BiologicalProducts

TRex Bio, Inc. filed for an IPO
TRex Bio, Inc., a US-based biotech company, has filed for an IPO. They specialize in partnerships within the field, generating revenue from collaborative agreements.
Biotech

#IPO #Biotech #BiologicalProductsNoDiagnostic #UnitedStates #IPONews #biologicalproducts

Electra Therapeutics, Inc. set an expected IPO date
Electra Therapeutics has set an expected IPO date of September 17, 2026, as it focuses on precision medicines for…
Biotech

#IPO #Biotech #BiologicalProductsNoDiagnostic #UnitedStates #IPONews #BiologicalProducts #Cancer #Immunotherapy

Electra Therapeutics, Inc. filed for an IPO
Electra Therapeutics, Inc. has filed for its IPO. This late clinical-stage biopharma focuses on precision medicines for immune-mediated diseases and cancer.
Biotech

#IPO #Biotech #BiologicalProductsNoDiagnostic #UnitedStates #IPONews